ChemBridge Corporation
11199 Sorrento Valley Road
Suite 206
San Diego
California
92121
United States
Tel: 858-451-7400
Fax: 858-451-7401
Website: http://www.chembridge.com/
Email: sales@chembridge.com
About ChemBridge Corporation
ChemBridge Corporation offers an extensive portfolio of chemistry products and research services for drug discovery, including small molecule screening libraries, building blocks for medicinal chemists, and discovery chemistry services. Our screening libraries offer over 800,000 leadlike and druglike molecules, including both diverse and targeted/focused screening compounds and selections. For synthesis of advanced molecules for drug discovery, our building block collection provides over 12,000 molecules including aldehydes, carboxylic acids, primary amines, boronic acids, and many other classes. Our chemistry services include custom synthesis, exclusive library synthesis, and FTE-based medicinal chemistry support.
ChemBridge provides a comprehensive portfolio of cost-effective, enabling chemistry solutions for all stages of small molecule drug discovery, from initial hit generation, to hit-to-lead, to lead optimization, and pre-clinical candidate identification.
8 articles about ChemBridge Corporation
-
ChemBridge Corporation Release: Chem-Space Launches To Provide Largest Global Chemical Database And Search Tool
3/1/2016
-
Evotec AG to Strengthen Its Compound Collection Through a Collaboration With ChemBridge Corporation
2/15/2011
-
ChemBridge Corporation and Collaborative Drug Discovery, Inc. Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers' Own Private Data
9/2/2009
-
ChemBridge Corporation Enters Into New Discovery Chemistry Strategic Alliance With AstraZeneca PLC (JOBS)
9/24/2008
-
ChemBridge Corporation Launches Newly Redesigned Hit2Lead.com Online Chemical Store
10/3/2007
-
ChemBridge Corporation Announces Their New Fragment Library For Screening
1/10/2007
-
ChemBridge Corporation Libraries Most Leadlike/Diverse In Independent Study
11/30/2006
-
ChemBridge Corporation And ChemBridge Research Laboratories, Inc. Enter Into Discovery Chemistry Strategic Alliance With AstraZeneca PLC
9/21/2006